Zooming in on the latest balance sheet data, we can see that MACA had liabilities of AU$414.9m due within 12 months and liabilities of AU$206.3m due beyond that.

MirLand Development Corp. PLC annual balance sheet for MLD.M.IL company financials.

Expected clinical package for OTL-200 BLA for MLD using data from existing patients clarified with FDA Guidance obtained on design of OTL-203 global registrational trial for MPS-IH Enrollment goal ...

Seventeen of 18 pre-symptomatic late infantile patients maintained the ability to walk at last assessment (GMFC-MLD Level 2 or better; range of age at last assessment: 3.2 to 13.4 years), in ...

--Homology Medicines, Inc., a genetic medicines company, announced today the presentation of preclinical data that support its investigational gene therapy programs for the treatment of ...

Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD ...

Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD ...

Expected clinical package for OTL-200 BLA for MLD using data from existing patients clarified with FDA Guidance obtained on design of OTL-203 global registrational trial for MPS-IH Enrollment goal met ...